Author

Michael Sturdivant

University of North Carolina at Chapel HillORCID 0000-0002-2830-3922Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Balamayooran TheivanthiraniD· 1 shared Brent Allen HanksiD· 1 shared Georgia Marie BeasleyiD· 1 shared Kaylee A. VillarrealiD· 1 shared Michael AksuiD· 1 shared Michael P. PlebanekiD· 1 shared Nagendra Sastry YarlaiD· 1 shared Nicholas C. DeVitoiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Balamayooran TheivanthiranORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Gli2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating Wnt Ligand and Prostaglandin Signaling

Nicholas C. DeVito, Y‐Van Nguyen, Michael Sturdivant, Michael P. Plebanek, Kaylee A. Villarreal, Nagendra Sastry Yarla, Vaibhav Jain, Michael Aksu, Georgia Marie Beasley, Balamayooran Theivanthiran, Brent Allen Hanks

This paper identifies Gli2 as a key driver of immune evasion and immunotherapy resistance in tumors through Wnt and prostaglandin signaling, offering a therapeutic target for combination immunotherapies.

Cancer Research · Feb 19, 2025Peer-reviewedCancer Biology